ABVC BioPharma Inc./$ABVC
1D1W1MYTD1Y5YMAX
About ABVC BioPharma Inc.
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.
- Ticker
- $ABVC
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- -
- Headquarters
- Fremont, United States
- Website
- www.abvcpharma.com
ABVC Metrics
BasicAdvanced
$22M
-
-$0.29
0.63
-
Price and volume
Market cap
$22M
Beta
0.63
52-week high
$3.40
52-week low
$0.71
Average daily volume
97K
Financial strength
Current ratio
0.072
Quick ratio
0.023
Long term debt to equity
11.455
Total debt to equity
23.533
Interest coverage (TTM)
-41.98%
Profitability
EBITDA (TTM)
-6.491
Effective tax rate (TTM)
-0.01%
Management effectiveness
Return on assets (TTM)
-22.85%
Return on equity (TTM)
-69.86%
Valuation
Price to book
2.06
Price to tangible book (TTM)
2.06
Price to free cash flow (TTM)
-7.679
Free cash flow yield (TTM)
-13.02%
Free cash flow per share (TTM)
-0.108
Growth
Earnings per share change (TTM)
-2.25%
3-year earnings per share growth (CAGR)
-57.80%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.